These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of protein losing enteropathy due to idiopathic intestinal lymphangiectasis by parenteral nutrition. Wagner A Digestion; 1969; 2(3):167-71. PubMed ID: 4978356 [No Abstract] [Full Text] [Related]
3. Noonan syndrome with intestinal lymphangiectasis. A metabolic and anatomic study. Vallet HL; Holtzapple PG; Eberlein WR; Yakovac WC; Moshang T; Bongiovanni AM J Pediatr; 1972 Feb; 80(2):269-74. PubMed ID: 5008823 [No Abstract] [Full Text] [Related]
4. Primary intestinal lymphangiectasia: surgical implications. Muzaffar K; Block MA; Fox TA Am Surg; 1972 May; 38(5):288-91. PubMed ID: 5026674 [No Abstract] [Full Text] [Related]
5. [Medium-chain fats in dietetic treatment of some disorders of the digestive tract]. Foltyn H; Korzon M Pol Tyg Lek; 1972 Jul; 27(31):1207-10. PubMed ID: 4561156 [No Abstract] [Full Text] [Related]
6. Dietary treatment of protein-losing enteropathy. Yssing M; Jensen H; Jarnum S Acta Paediatr Scand; 1967 Mar; 56(2):173-81. PubMed ID: 6072275 [No Abstract] [Full Text] [Related]
7. Use of medium-chain triglyceride diets in children with malabsorption. Leyland FC; Fosbrooke AS; Lloyd JK; Segall MM; Tamir I; Tomkins R; Wolff OH Arch Dis Child; 1969 Apr; 44(234):170-9. PubMed ID: 5779428 [No Abstract] [Full Text] [Related]
9. Studies of the immunologic defects associated with intestinal lymphangiectasia, with some observations on dietary control of chylous ascites. McGuigan JE; Purkerson ML; Trudeau WL; Peterson ML Ann Intern Med; 1968 Feb; 68(2):398-404. PubMed ID: 4181615 [No Abstract] [Full Text] [Related]
10. DIETARY TREATMENT OF PROTEIN LOSS IN INTESTINAL LYMPHANGIECTASIA. THE EFFECT OF ELIMINATING DIETARY LONG CHAIN TRIGLYCERIDES ON ALBUMIN METABOLISM IN THIS CONDITION. HOLT PR Pediatrics; 1964 Nov; 34():629-35. PubMed ID: 14227642 [No Abstract] [Full Text] [Related]
11. Medium chain triglycerides (MCT) in the treatment of protein-losing enteropathy and malabsorption syndromes. Jarnum S; Jensen H Scand J Gastroenterol; 1966; 1(4):306-13. PubMed ID: 5966089 [No Abstract] [Full Text] [Related]
12. TREATMENT OF MALABSORPTION SYNDROME AND EXUDATIVE ENTEROPATHY WITH SYNTHETIC MEDIUM CHAIN TRIGLYCERIDES. HOLT PR; HASHIM SA; VANITALLIE TB Am J Gastroenterol; 1965 Jun; 43():549-59. PubMed ID: 14296654 [No Abstract] [Full Text] [Related]
13. Intestinal lymphangiectasia with immunoglobulin A deficiency. Eisner JW; Bralow SP Am J Dig Dis; 1968 Dec; 13(12):1055-64. PubMed ID: 4177544 [No Abstract] [Full Text] [Related]
14. The D-xylose tolerance test in patients with gluten-sensitive enteropathy and generalized dermatitis. Kendrick-Doran C; Everett MA; Welsh JD Arch Dermatol; 1966 Nov; 94(5):574-6. PubMed ID: 5960359 [No Abstract] [Full Text] [Related]
15. [The diet with medium chain triglycerides. Indications and applications]. Hooft C; Kriekemans J Verh K Vlaam Acad Geneeskd Belg; 1968; 30(6):291-332. PubMed ID: 5716070 [No Abstract] [Full Text] [Related]